DLA Piper advises Locanabio in its US$100 million Series B financing
12/15/20, 9:14 PM
Location
new yorkMoney raised
$100 million
Round Type
series b
DLA Piper represented Locanabio, an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, in its recent US$100 million Series B financing led by Vida Ventures.
Company Info
Location
new york, new york, united states
Additional Info
DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising. dlapiper.com
SOURCE DLA Piper